Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Pharmacology & Therapeutics|July 6, 2019
TP53 in bone and soft tissue sarcomasElizabeth Thoenen, Amanda Curl, Tomoo IwakumaCell Death and Differentiation|December 15, 2017
The interplay between mutant p53 and the mevalonate pathwayAlejandro Parrales, Elizabeth Thoenen, Tomoo IwakumaNature Communications|March 11, 2025
Suppression of stress granule formation is a vulnerability imposed by mutant p53Elizabeth Thoenen, Atul Ranjan, Alejandro Parrales, et al.Cancers|January 21, 2023
Drugs Targeting p53 Mutations with FDA Approval and in Clinical TrialsShigeto Nishikawa, Tomoo IwakumaInternational Journal of Molecular Sciences|December 24, 2021
Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family MembersAtsushi Kaida, Tomoo IwakumaMolecular Cancer Research : MCR|January 7, 2004
MDM2, an introductionTomoo Iwakuma, Guillermina LozanoCancers|December 23, 2018
Regulators of Oncogenic Mutant TP53 Gain of FunctionSatomi Yamamoto, Tomoo IwakumaCancer Research|June 17, 2020
TAp63-miRNA-AURKA Axis as a Therapeutic Target for Cutaneous Squamous Cell CarcinomaAlejandro Parrales, Tomoo IwakumaInternational Journal of Molecular Sciences|December 13, 2016
Non-Canonical Cell Death Induced by p53Atul Ranjan, Tomoo IwakumaFrontiers in Oncology|January 7, 2016
Targeting Oncogenic Mutant p53 for Cancer TherapyAlejandro Parrales, Tomoo IwakumaPageof 7